GlycoMimetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.05.24	Why Is GlycoMimetics Stock Falling In Pre-market? (RTTNews)
04.01.24	GlycoMimetics' GMI-1687 Meets Primary Goal In Phase 1a Study (RTTNews)
23.10.23	Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board (PR Newswire)
06.09.22	GlycoMimetics Says Edwin Rock Joins As Chief Medical Officer (RTTNews)
29.04.22	ACCD Guides Q1 Well Below Analysts' Estimates, ALNY Cuts Outlook, NVCR Braces For Busy Year (RTTNews)
12.07.21	GlycoMimetics Announces Initiation Of Clinical Trial On Acute Myeloid Leukemia (RTTNews)
06.10.20	Pre-market Movers In Healthcare Sector: XTNT, BNTX, GLYC, ALNA, MGEN, IOVA, ARTL… (RTTNews)
06.10.20	GSK, AZN 1st To Use NVDA's Supercomputer, IOVA To Delay BLA Filing, YMAB Plunges, GLYC On Watch (RTTNews)
06.10.20	After Market Hours: Alteryx, GlycoMimetics, Spartan Energy Gain; Iovance, Y-mAbs Slip (RTTNews)
22.11.19	FDA Approves AZN's Calquence, GLYC's Data To Be Delayed, ENLV Withdraws Offering (RTTNews)
06.08.19	5 Top Losers In Healthcare Sector (GLYC, LOGC, KZR…) (RTTNews)
19.01.18	BGNE Up, Up And Away, Data Vindicates CGEN's Strategy, JNCE Awaits ICONIC Data (RTTNews)
13.12.17	GLYC On The Move, ATNX Rises On KX2-391 Deal, Three Cheers For PTI (RTTNews)
02.12.17	ASH: CBIO Awaiting Next Catalyst, BLUE In The Pink, STML Keeps Growing (RTTNews)
28.11.17	CDNA, ALNA Up On Analyst Coverage, LIFE Goes Ahead, GLYC Gearing Up For ASH (RTTNews)
07.11.17	TXMD To Resubmit TX-004HR NDA Soon, FLGT Optimistic, MLAB Disappoints (RTTNews)
19.09.17	NBRV Leaps On Study Data, CSII Takes A Hit, CLVS Abuzz, New Dimension For DMTX (RTTNews)
05.09.17	Stocks Under Scanner in the Biotech Space -- GlycoMimetics, Genocea Biosciences, Inotek Pharma, and Loxo Oncology (PR Newswire)
28.06.17	Technical Snapshots for These Biotech Stocks -- Merrimack Pharma, MannKind, GlycoMimetics, and Radius Health (PR Newswire)
06.06.17	Gainers & Losers Of June 5: LOXO, CLSN, RDUS, GLYC, JUNO... (RTTNews)
31.05.17	ALBO Spikes, GLYC Abuzz, FDA Approves 1st Generic Strattera For ADHD (RTTNews)
24.05.17	Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE... (RTTNews)
23.05.17	FDA Approves 1st Drug For GCA, Puma Leaps, Will SBPH Spring A Surprise? (RTTNews)
19.05.17	Company Spotlight: GlycoMimetics (RTTNews)
18.05.17	SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall (RTTNews)
03.03.16	OPXA Hands Out Pink Slips, KOOL Not So Hot, Time To Follow RVNC (RTTNews)
24.06.15	EYES Turns Vision Into Reality, QDEL Gets FDA Nod, Watch Out For ADHD (RTTNews)
23.06.15	GlycoMimetics To Receive $20 Mln. Milestone Payment From Pfizer (RTTNews)
20.05.15	ACHN Cuts A Deal For HCV Assets, LuViva Snubbed Again, Medidur Proves Safe (RTTNews)
15.05.15	ChromaDex In Full Color, TCON On Fast Track, FDA's Glad Tidings For GLYC (RTTNews)
08.04.15	RGLS Up After Hours, GLYC Has Some Good News, Panther On The Prowl (RTTNews)
07.04.15	GlycoMimetics Says Pfizer Plans To Initiate Phase 3 Trial With Rivipansel (RTTNews)
29.09.14	AMBI Snapped Up, ALIM's Iluvien Gets FDA Nod, GLYC Faces Glitch In Study (RTTNews)
26.09.14	GlycoMimetics Reports Delay In Initiation Of Phase 3 Trial With Rivipansel (RTTNews)
01.07.14	GlycoMimetics Announces Agreement With FDA On Rivipansel (RTTNews)
19.06.14	GlycoMimetics Begins Phase 1 Trial Of GMI-1271 For Blood-Related Cancers (RTTNews)
08.05.14	GlycoMimetics Posts Q1 Loss (RTTNews)
31.03.14	GlycoMimetics Posts Loss (RTTNews)
15.01.14	GlycoMimetics Closes $64.4 Mln IPO (RTTNews)
28.10.13	GlycoMimetics To Price 4 Mln Shares IPO Between $14 And $16/shr - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu GlycoMimetics Inc

Aktien Top/Flop

Meistgelesene Nachrichten